Biotech Values

[DewDiligence]

>Medicure to Host Analyst & Investor Day<

I listened to the webcast and was not especially impressed. They really have no plan to make Aggrastat a commercial hit in the U.S. It sells well abroad, but that’s only because it’s cheap.

I wanted to hear about MCU’s preclinical thrombin and platelet inhibitor, but they didn’t have time to cover it.